Business mogul Kevin O’Leary wants to invest in a US refinery, says fossil fuels will stick around
April 13, 2023
Comedian and podcaster Joe Rogan announced he tested positive for COVID-19 and used ivermectin to treat it.
“I got back from the road Saturday night feeling very weary,” Rogan said in a video. “I had a headache, and I just felt just run down. And just to be cautious, I separated from family, slept in a different part of the house, and throughout the night, I got fevers and sweats, and I knew what was going on. So, I got up in the morning, got tested, and it turns out I got COVID.”
Along with the controversial ivermectin treatment, Rogan took monoclonal antibodies. While the Food and Drug Administration (FDA) now suggests ivermectin is not appropriate for treating COVID-19, the agency previously approved the drug and claimed it was “found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro.”
A December 2020 study published in the National Library of Medicine concluded, “A 5-day course of ivermectin was found to be safe and effective in treating adult patients with mild COVID-19.” In recent weeks, the FDA referred to ivermectin as a horse drug, since it is also used to treat parasitic infections.
Critics claim the agency is walking back on its previously expressed benefits of ivermectin in the treatment of COVID-19 because it is a cheap drug. They suggest the agency would rather promote the money-making vaccine, as it has internal connections to pharmaceutical companies.
For instance, Scott Gottlieb, former commissioner of the FDA from 2017 to 2019, now sits on the board of directors at Pfizer. Johnson & Johnson, Moderna, and Pfizer stand to make over 100 billion in revenue from COVID-19 vaccines.
In an update to his followers, Rogan said, “We immediately threw the kitchen sink at it: all kinds of meds. Monoclonal antibodies, Ivermectin, Z-pack, Prednisone — everything. I also got an NAD drip and a vitamin drip, and I did that three days in a row, and so here we are on Wednesday, and I feel great.”
ARTICLE: ANTOINETTE AHO
MANAGING EDITOR: CARSON CHOATE
PHOTO CREDITS: CNBC